This suggests a significant association with IgA+ and IgA- gut microbiota in postmenopausal women with breast cancer, suggesting that the gut microbiota may influence breast cancer risk through altered metabolism, estrogen cycling and immune pathways. The gene discussed is CD79A; the disease is breast cancer.